Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

Post time 2022-8-22 16:33:25

journal：Nature Communications

Authors：Joao M. Fernandes Neto; Ernest Nadal; Evert Bosdriesz; Salo N. Ooft; Lourdes Farre; Chelsea McLean; Sjoerd Klarenbeek; Anouk Jurgens; Hannes Hagen; Liqin Wang; Enriqueta Felip; Alex Martinez-Marti; August Vidal; Emile Voest; Lodewyk F. A. Wessels; Olaf van Tellingen; Alberto Villanueva; René Bernards

Published date：2020-12-

DOI：10.1038/s41467-020-16952-9

Article link：http://dx.doi.org/10.1038/s41467-020-16952-9

Article Source：Springer Science and Business Media LLC。

Remark：

Post time 2022-8-22 16:33:26

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-8-22 16:35:32

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-8-30 16:35:03

: This post has been completed
Completed attachments will be deleted within 24 hours.

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours